<DOC>
	<DOCNO>NCT01262794</DOCNO>
	<brief_summary>To evaluate safety tolerability CDP6038 follow single dose subcutaneous ( sc ) administration CDP6038 Japanese subject . To evaluate Pharmacokinetics CDP6038 follow single dose sc administration CDP6038 Japanese subject</brief_summary>
	<brief_title>Pharmacokinetic ( PK ) /Pharmacodynamic ( PD ) , Study Single-dose Subcutaneous CDP6038 Healthy Japanese Male Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy Japanese volunteer Subject participated clinical drug study ( include biologic product medical device ) within 5 PK halflives 3 month ( whichever longer ) prior Screening , subject currently participate another clinical study . Subject healthy ( eg , take drug treatment , psychological emotional problem , drug/alcohol abuse history drug/alcohol abuse , abnormal safety parameter )</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Healthy volunteer</keyword>
	<keyword>Japanese</keyword>
</DOC>